8 completed, 2 unknown, 1 enrolling by invitation, 1 not yet recruiting. 13 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 13 | Completed 8, Unknown 2, Enrolling by invitation 1, Not yet recruiting 1, Terminated 1 |
Follow Fasting: new trials by email Literature Review of Fasting trials Research Report on Fasting
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Effect of an Early Time Restricted Eating Mediterranean Diet Compared to Naltrexone/Bupropion on Liver Fibrosis in People With Cardiometabolic Risk Factors in a Hospital Outpatient Clinic (MEDFAST-study) early time restricted Mediterranean diet, Mysimba - Diabetes Mellitus, Type 2, Liver Fibrosis | Phase 4 | Enrolling by invitation | Carmen Dietvorst | 70 | 2025-04-14 | 2026-04-21 |
| Ramadan Fasting Outcomes in Patients With Secondary Adrenal Insufficiency Before and After the Treatment of Hypotension. Fludrocortisone 0.1 Milligrams (mg) - Secondary Adrenal Insufficiency, Hypotension | Phase 4 | Not yet recruiting | Hopital La Rabta | 20 | 2025-02-15 | 2025-02-18 |
| A Study of Tirzepatide (LY3298176) in Participants With Type 2 Diabetes During Ramadan Tirzepatide - Type 2 Diabetes | Phase 4 | Completed | Eli Lilly and Company | 166 | 2024-10-11 | 2026-05-22 |
| Effect of Premedicant Oral Paracetamol on Gastric Volume and pH Paracetamol, Standard care - Fasting | Phase 4 | Unknown | King's College Hospital NHS Trust | 104 | 2020-10-06 | 2021-02-21 |
| Sex Differences in Myocardial Steatosis Induced Left Ventricular Dysfunction Estradiol patch, Cetrotide, Fasting - Heart Diseases, Left Ventricular Dysfunction | Phase 4 | Unknown | The University of Texas at Arlington | 100 | 2018-09-13 | 2024-02-20 |
| Ramadan Fasting in Patients With Corticotrope Deficiency Treated Either by Hydrocortisone or by Prednisolone Hydrocortisone, Prednisolone - Corticotropin Deficiency, Fasting | Phase 4 | Completed | University Tunis El Manar | 53 | 2018-05-17 | 2019-04-29 |
| Dosage Reduction and Acute Glycemic Complications in People With Type 2 Diabetes Who Fast During Ramadan Metformin and Glimepiride (Low Dosage), Metformin and Vildagliptin (Low Dosage), Metformin and Insulin Glargine U100 (Low Dosage) - Diabetes Mellitus, Type 2 | Phase 4 | Completed | University of Jordan | 687 | 2017-02-14 | 2020-02-11 |
| Efavirenz Comparative Bioavailability Efavirenz 600 Test-Stocrin 600 Reference, Stocrin 600 Reference-Efavirenz 600 Test - Healthy | Phase 4 | Completed | Center for Clinical Pharmacology Research Bdbeq S.A. | 12 | 2013-04-01 | 2013-08-14 |
| Management of Type-2 Diabetic Patients Treated With Insulin During the Ramadan Insulin treatment during Ramadan, Standard of care - Diabetes Type 2, Treatment During Ramadan | Phase 4 | Completed | Meir Medical Center | 245 | 2011-09-01 | 2013-04-12 |
| Trial for People With Established Type 2 Diabetes During Ramadan Liraglutide, Sulfonylurea or Pioglitazone, Maintain dual therapy (Sulf/Pio) as comparator to Liraglutide - Type 2 Diabetes | Phase 4 | Completed | University of Leicester | 99 | 2011-04-01 | 2020-01-30 |
| Trial of Etoricoxib (Arcoxia) Taken Prophylactically to Prevent Ramadan Headache Etoricoxib, Placebo - Headache, Fasting | Phase 4 | Completed | Hartford Hospital | 220 | 2010-07-01 | 2011-03-08 |
| Sitagliptin Versus Sulphonylurea in Type 2 Diabetes During Ramadan Sitagliptin, sulphonylurea - Diabetes, Hypoglycemia | Phase 4 | Terminated | University of Manchester | 22 | 2008-08-01 | 2010-01-12 |
| Enteral Nutrition in Acute Pancreatitis Enteral nutrition - Acute Pancreatitis | Phase 4 | Completed | University Hospital Rijeka | 214 | 2007-05-01 | 2015-04-03 |
Diabetes Mellitus, Type 2 (5) · Diabetes Mellitus (3) · Hypoglycemia (3) · Intermittent Fasting (2) · Adrenocorticotropic hormone deficiency (1) · Diabetic Ketoacidosis (1) · Dyslipidemias (1) · Fatty Liver (1) · Headache (1) · Heart Diseases (1) · Hyperglycemia (1) · Hyperglycemic Hyperosmolar Nonketotic Coma (1) · Hypertension (1) · Hypotension (1)
Behavior (13) · Feeding Behavior (13) · Glucose Metabolism Disorders (7) · Metabolic Diseases (7) · Nutritional and Metabolic Diseases (7) · Endocrine System Diseases (6) · Cardiovascular Diseases (3) · Diabetes Mellitus (3) · Digestive System Diseases (2) · Pathological Conditions, Signs and Symptoms (2) · Signs and Symptoms (2) · Vascular Diseases (2) · Acid-Base Imbalance (1) · Acidosis (1)
Standard of Care (2) · Sulfonylurea Compounds (2) · Acetaminophen (1) · Angptl4 protein, mouse (1) · Bupropion (1) · Diet Therapy (1) · Diet, Mediterranean (1) · Enteral Nutrition (1) · Etoricoxib (1) · Hydrocortisone (1) · Insulin (1) · Liraglutide (1) · Lower Body Negative Pressure (1) · Metformin (1) · Naltrexone (1)
Carmen Dietvorst (1) · Center for Clinical Pharmacology Research Bdbeq S.A. (1) · Eli Lilly and Company (1) · Hartford Hospital (1) · Hopital La Rabta (1) · King's College Hospital NHS Trust (1) · Meir Medical Center (1) · The University of Texas at Arlington (1) · University Hospital Rijeka (1) · University Tunis El Manar (1) · University of Jordan (1) · University of Leicester (1) · University of Manchester (1)
United Kingdom (3) · Israel (2) · Tunisia (2) · Jordan (1) · Netherlands (1) · Saudi Arabia (1) · United Arab Emirates (1) · United States (1) · Uruguay (1)
Naim Shehadeh, MD (2) · Ayman A. Zayed, MD (1) · Emily Saffer, MB BS (1) · Francisco E. Estevez, M.D. (1) · Hedia Slimane, MD (1) · Manuel Castro Cabezas, Dr. (1) · Melanie J D (1) · Rayaz A Malik, MBChB, PhD (1) · Zev Wimpfheimer, MD (1)
PMID 21848948, PMID 26234442, PMID 27107634, PMID 34305809, PMID 35166373, PMID 42350004